[1]ChemicalandPharmaceuticalBulletin,1980,vol.28,#10,p.3020-3028
[1]ChemicalandPharmaceuticalBulletin,1980,vol.28,#10,p.3020-3028
[1]ChemicalandPharmaceuticalBulletin,1980,vol.28,#10,p.3020-3028
[1]ChemicalandPharmaceuticalBulletin,1980,vol.28,#10,p.3020-3028
[1]ChemicalandPharmaceuticalBulletin,1980,vol.28,#10,p.3020-3028
[1]ChemischeBerichte,1910,vol.43,p.334
[1]JournalfurpraktischeChemie(Leipzig1954),1877,vol.<2>16,p.442
[1]Patent:DE234217, Fortschr.Teerfarbenfabr.Verw.Industriezweige,vol.10,p.1118
[1]ChemischeBerichte,1902,vol.35,p.3653
[1]JournaloftheAmericanChemicalSociety,1951,vol.73,p.2723
Title: Mitchell JA, et al. Sodium salicylate inhibits cyclo-oxygenase-2 activity independently of transcription factor (nuclear factor kappaB) activation: role of arachidonic acid. Mol Pharmacol. 1997 Jun;51(6):907-12.
Title: Nixon M, et al. Salicylate downregulates 11β-HSD1 expression in adipose tissue in obese mice and in humans, mediating insulin sensitization. Diabetes. 2012 Apr;61(4):790-6.